These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 27288457)

  • 21. Many facets of the peripheral myelin protein PMP22 in myelination and disease.
    Naef R; Suter U
    Microsc Res Tech; 1998 Jun; 41(5):359-71. PubMed ID: 9672419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelin is dependent on the Charcot-Marie-Tooth Type 4H disease culprit protein FRABIN/FGD4 in Schwann cells.
    Horn M; Baumann R; Pereira JA; Sidiropoulos PN; Somandin C; Welzl H; Stendel C; Lühmann T; Wessig C; Toyka KV; Relvas JB; Senderek J; Suter U
    Brain; 2012 Dec; 135(Pt 12):3567-83. PubMed ID: 23171661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electroceutical approach ameliorates intracellular PMP22 aggregation and promotes pro-myelinating pathways in a CMT1A in vitro model.
    Intisar A; Woo H; Kang HG; Kim WH; Shin HY; Kim MY; Kim YS; Mo YJ; Lee YI; Kim MS
    Biosens Bioelectron; 2023 Mar; 224():115055. PubMed ID: 36630746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
    Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
    Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distal enhancers upstream of the Charcot-Marie-Tooth type 1A disease gene PMP22.
    Jones EA; Brewer MH; Srinivasan R; Krueger C; Sun G; Charney KN; Keles S; Antonellis A; Svaren J
    Hum Mol Genet; 2012 Apr; 21(7):1581-91. PubMed ID: 22180461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease).
    Berger P; Niemann A; Suter U
    Glia; 2006 Sep; 54(4):243-57. PubMed ID: 16856148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1 A.
    Boutary S; Caillaud M; El Madani M; Vallat JM; Loisel-Duwattez J; Rouyer A; Richard L; Gracia C; Urbinati G; Desmaële D; Echaniz-Laguna A; Adams D; Couvreur P; Schumacher M; Massaad C; Massaad-Massade L
    Commun Biol; 2021 Mar; 4(1):317. PubMed ID: 33750896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10.
    Bondurand N; Girard M; Pingault V; Lemort N; Dubourg O; Goossens M
    Hum Mol Genet; 2001 Nov; 10(24):2783-95. PubMed ID: 11734543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distal axonopathy in peripheral nerves of PMP22-mutant mice.
    Sancho S; Magyar JP; Aguzzi A; Suter1 U
    Brain; 1999 Aug; 122 ( Pt 8)():1563-77. PubMed ID: 10430839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetraspan myelin protein PMP22 and demyelinating peripheral neuropathies: new facts and hypotheses.
    Müller HW
    Glia; 2000 Jan; 29(2):182-5. PubMed ID: 10625337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The modifying effect a PMP22 deletion in a family with Charcot-Marie-Tooth type 1 neuropathy due to an EGR2 mutation.
    Reményi V; Inczédy-Farkas G; Gál A; Bereznai B; Pál Z; Karcagi V; Mechler F; Molnár MJ
    Ideggyogy Sz; 2014 Nov; 67(11-12):420-5. PubMed ID: 25720245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves.
    Maier M; Berger P; Nave KA; Suter U
    Mol Cell Neurosci; 2002 May; 20(1):93-109. PubMed ID: 12056842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The "CMT rat": peripheral neuropathy and dysmyelination caused by transgenic overexpression of PMP22.
    Niemann S; Sereda MW; Rossner M; Stewart H; Suter U; Meinck HM; Griffiths IR; Nave KA
    Ann N Y Acad Sci; 1999 Sep; 883():254-61. PubMed ID: 10586250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropathy-associated Egr2 mutants disrupt cooperative activation of myelin protein zero by Egr2 and Sox10.
    LeBlanc SE; Ward RM; Svaren J
    Mol Cell Biol; 2007 May; 27(9):3521-9. PubMed ID: 17325040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Schwann cell transcript biomarkers for hereditary neuropathy skin biopsies.
    Svaren J; Moran JJ; Wu X; Zuccarino R; Bacon C; Bai Y; Ramesh R; Gutmann L; Anderson DM; Pavelec D; Shy ME
    Ann Neurol; 2019 Jun; 85(6):887-898. PubMed ID: 30945774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation.
    Giambonini-Brugnoli G; Buchstaller J; Sommer L; Suter U; Mantei N
    Neurobiol Dis; 2005 Apr; 18(3):656-68. PubMed ID: 15755691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1A.
    Atanasoski S; Scherer SS; Nave KA; Suter U
    J Neurosci Res; 2002 Feb; 67(4):443-9. PubMed ID: 11835311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot-Marie-Tooth-related diseases.
    Shames I; Fraser A; Colby J; Orfali W; Snipes GJ
    J Neuropathol Exp Neurol; 2003 Jul; 62(7):751-64. PubMed ID: 12901701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression.
    Fortun J; Go JC; Li J; Amici SA; Dunn WA; Notterpek L
    Neurobiol Dis; 2006 Apr; 22(1):153-64. PubMed ID: 16326107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.